Stay Connected
Join us on Facebook Follow us on linked in Follow us on YouTube Follow us on Vimeo
Gastroenterology-GI drug development clinical trial support - Medpace gastroenterology - GI CRO
Gastroenterology Clinical Research
request info
First Name*:
Last Name*:
Company*:
Email*:
Leave a Message:


Please enter the security code


Find out how our medical, regulatory, and operational expertise in gastroenterology clinical development can help with your next GI study or program.


Learn More

Clinical drug development for digestive disorders and diseases, such as inflammatory bowel disease and functional GI disorders, presents a unique set of challenges for developing new and effective treatments. Medpace, a therapeutically-specialized gastroenterology CRO, can help Sponsors design and execute drug development strategies while also providing critical integrated services such as centralized imaging and central labs.

Therapeutic Leadership Across Multiple Indications

As a physician-led, therapeutically-focused global CRO, Medpace offers medical leadership in GI, as well as other areas that may cross over into GI studies including Infectious Disease, Metabolic/Diabetes, and Oncology. Our team approach provides sponsors with valuable insights from highly experienced medical doctors into studies that touch on multiple indications.  In addition, Medpace employs a seasoned team of CTMs, CRAs, data managers, statisticians, safety managers, medical writers, and regulatory managers who are focused on serving sponsors in all of your clinical development needs.

Gastrointestinal Drug Development Expertise

  • Inflammatory Bowel Disease including:
    • Ulcerative Colitis
    • Crohn's Disease
  • Functional GI Disorders including:
    • Chronic Idiopathic Constipation (also drug-induced constipation)
    • Irritable Bowel Syndrome
    • Postprandial Distress and Gastroparesis (also GERD)
  • Liver Disease including:
    • Viral Hepatitis
    • Nonalcoholic steatohepatitis (NASH)

Central Imaging

Endoscopy has become a standard outcome measure in many GI indications including IBD. The concept of mucosal healing and deep remission in Crohn’s Disease and Ulcerative Colitis has gained momentum with regulators and prescribers. Centralized imaging allows for standardization of patient inclusion and outcome assessment. Imaging Core Lab, a wholly owned subsidiary of Medpace, provides holistic central imaging service including site assessment, qualification and training, recording equipment provisioning, image processing (blinding and quality control) and expert evaluation.

Full-service Central Lab for GI Studies

Medpace Reference Labs (MRL) provides global central laboratory services through four wholly owned labs located in Belgium, China, Singapore and the USA. Unlike other global central labs that are grown through acquistion, MRL labs were custom built and offer identical testing platforms, reagents, calibration and QC to ensure identical results globally. As a full service central lab, MRL can help design and execute your protocol testing needs with a strong selection of inflammatory biomarkers and cytokines.